Issued Patents 2025
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428420 | Tricyclic heterocycles as FGFR inhibitors | Robert Swyka, Evan Styduhar, Xin Li, Oleg Vechorkin | 2025-09-30 |
| 12384778 | Pyrazolopyridine compounds and uses thereof | Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang +2 more | 2025-08-12 |
| 12378243 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more | 2025-08-05 |
| 12331063 | Hetero-bicyclic inhibitors of KRAS | Alexander Sokolsky, Chang Min, Xiaozhao Wang | 2025-06-17 |
| 12312331 | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors | Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Liangxing Wu +4 more | 2025-05-27 |
| 12247038 | Pyrido[3,2-d]pyrimidine compounds as immunomodulators | Jingwei Li, Liangxing Wu | 2025-03-11 |
| 12247026 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li | 2025-03-11 |
| 12201636 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Andrew P. Combs, Eddy W. Yue, Song Mei, Joseph Glenn +2 more | 2025-01-21 |
| 12187725 | Tricyclic urea compounds as JAK2 V617F inhibitors | Yanran Ai, Yu Sheng Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol +5 more | 2025-01-07 |
| 12187743 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Kaijiong Xiao | 2025-01-07 |